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Abstract. Min is a fully penetrant dominant mutation
that leads to the development of multiple intestinal
adenomas throughout the duodenal-to-colonic axis.
Minl+ C57BL6/J mice have an average life-span of
120 d. Mufti-label immunocytochemical studies of
these lesions demonstrate patches of differentiated en-
terocytes, and scattered enteroendocrine, goblet and
Paneth cells. Expression of endogenous marker genes
within these differentiated cells can be directly cor-
related with the position occupied by the adenoma
along the duodenal-to-colonic axis and mirrors the re-
gional differentiation of the normal gut epithelium.
The presence of multiple lineages in adenomas to-
gether with their retention of spatial information sug-
gests that tumorigenesis in Minl+ mice may be initi-
ated in a multipotent stem cell normally located at the
base of intestinal crypts. To study the time-dependent
properties of these tumors, genetic conditions were
T
HE mouse intestinal epithelium undergoes perpetual
renewal of its four principal terminally differentiated
cell types: the polarized absorptive enterocyte, the
mucus-producing goblet cell, a complex population of en-
teroendocrine cells, and the defensin/lysozyme containing
Paneth cell which is thought to function as part ofthe biolog-
ical barrier to bacterial translocation across the gut (reviewed
in Gordon, 1989) . Renewal and differentiation are rapid, ex-
traordinarily well organized in several spatial dimensions,
and dependent upon multipotent stem cells that are function-
ally anchored at the base of intestinal crypts (Cheng and Le-
blond, 1974). In the adult small intestine, 6-10 crypts, each
composed of -250 cells, surround each villus. ['H]Thymi-
dine labeling studies indicate that 150 cells, located in the
middle portion of each crypt, pass through the cell cycle
every 12 h resulting in the generation of 300 new cells/
crypt/d (reviewed in Potten and Loefer, 1990). These cells
undergo a bipolar migration. -12 cells emerge from each
crypt per hour and are translocated in coherent vertical bands
up the adjacent villus (Cheng and Leblond, 1974; Potten and
Loefer, 1990; Schmidt et al., 1985b). Differentiation ofen-
terocytes, goblet and enteroendocrine cells occurs during
this upward migration which is completed in 3 d when the
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sought in which Minl+ animals could survive for up
to 300 d. Min is fully penetrant in hybrids with either
AKR/J or MA/MyJ. However, the hybrids demonstrate
a reduction in the number of intestinal adenomas. Pre-
liminary backcross analysis is consistent with a single
major modifier locus unlinked to Min in both the
AKR/J and MA/MyJ strains. The increased lifespan of
the hybrid animals is also associated with the develop-
ment of invasive tumors. New tumors do not arise con-
tinuously over the lifespan of these animals; instead all
adenomas appear to be established by 100 d of age or
sooner. These studies indicate that the Minl+ mouse
is a powerful model system for analyzing the mecha-
nisms that establish and maintain a balance between
proliferation and differentiation in the continuously re-
newing gut epithelium and for an assessment of the
multi-step hypothesis of intestinal neoplasia.
cellsare exfoliated into the gut lumen at the apical extrusion
zone of the villus. Each villus contains a steady state level
of -3,500 surface epithelial cells and sheds -1,400 cells/
day resulting in a net loss of 2 x 101 cells/small bowel/d
(Potten and Loeffier, 1990). Paneth cells differentiate during
a downward journey to the base of the crypt where they re-
side for -3 wk before they are removed by mechanisms yet
to be fully defined. Epithelial cell migration and differentia-
tion are also closely coupled in the mouse colon. As cells
emerge from the colonic crypt, they form a hexagonal shaped
cuff that surrounds the crypt orifice. This cuff represents
the homolog of the small intestinal villus (Schmidt et al.,
1985b).
Normal (Cheng and Leblond, 1974; Winton et al., 1988;
Griffiths et al., 1988; Winton et al ., 1989 ; Winton and Pon-
der, 1990; Schmidt et al ., 1990), chimeric (Ponder et al.,
1985; Schmidt et al., 1985a,b, 1988), and transgenic (Cohn
et al., 1991) mice have been used to characterize the stem
cell organization of the gut epithelium. The receptor for the
Dolichos biforins agglutinin lectin encoded by the Dlb1
gene located on chromosome 11 (Uitderdyket al., 1986)has
been a particularly useful lineage marker for analyzing the
activity and biological properties of these stem cells. Inbred
1517strains with the Dlb1b allele will bind the lectin in their
crypt and villus epithelial cells whereas Dlb1°/Dlb-1° mice
are DBA-negative (Schmidt et al ., 1984, 1985a,ó). Analysis
of adult aggregation chimeras formed from Dlb-lb and Dlb-
1° homozygous embryos indicated that each adult small in-
testinal crypt is monoclonal: crypts contain either wholly
DBA-positive cellular populations or wholly negative popu-
lations-but never mixed populations (Ponder et al., 1985) .
In contrast, studies of the clonal organization of neonatal
chimeric gut revealed that, when crypts begin to form im-
mediately after birth, they are polyclonal. They subsequently
undergo conversion to monoclonality within the first 2 wk
after birth by an unknown mechanism that has been termed
purification (Schmidt et al., 1988).
An in vivo assay that detects somatic mutations at the
Dlb1 locus in (C57BL/6J x SWR) Fl mice that are Dlb1al
Dlb-Ib, has been used to characterize the stem cell organi-
zation ofthe mouse gut in greater detail (Winton et al ., 1988;
Winton and Ponder, 1990). The amplified clonal descen-
dants of mutated stem cells can be identified using histo-
chemical methods as unstained groups of cells in crypts or
on (polyclonal) villi that are otherwise DBA-positive. The
rate of spontaneous mutation defined by this assay appears
to be remarkably low : 0.5-13.5 mutations per 105 small in-
testinal crypts (or 104 villi) per year in untreated animals
(O'Sullivan et al., 1991; Winton et al., 1991). Treatment of
such mice with ethylnitrosurea (ENU) (Winton et al., 1988;
Winton and Ponder, 1990) or gamma irradiation (Winton et
al., 1989) results in the accumulation of monophenotypic,
DBA-negative crypts, suggesting that each small intestinal
crypt may ultimately be renewed by a single stem cell.
This view of the clonal organization of intestinal crypts is
independently supported by studies using the X chromosome-
linked polymorphic enzymes glucose-6-phosphate dehydrog-
enase (Griffiths et al ., 1988) and phosphoglycerate kinase
(Ponder et al ., 1985; Inoueet al., 1988), as lineage markers
and by analyses of transgenic mice containing fatty acid
bindingprotein/humangrowthhormonefusiongenes(Sweet-
ser et al., 1988a,ó ; Cohn et al., 1991; Roth et al ., 1991b).
Stem cells are generally defined by their high capacity for
self-renewal . Theirpotential for asymmetric division yields
one daughter that remains a stem cell (thus guaranteeing
self-maintenance) while the other undergoes commitment to
a differentiation program. Given the continuous and rapid
renewal of the mouse intestinal epithelium, the multipotent
small intestinal stem cell can be further characterized by its
enormous division potential. Estimates suggest that over the
3-yr lifespan ofa laboratory animal, each stem cell may un-
dergo 1,000 divisions (Potten and Loeffler, 1990). Another
feature is its ability to sustain geographic differences in the
differentiation program of its clonal descendants depending
upon its location along the duodenal-to-colonic axis. The
molecular mechanisms that sustain these regional differ-
ences are not known. However, experiments involving trans-
plantation of fetal gut, harvested before cytodifferentiation
of its epithelium, into the subcutaneous tissues of syngeneic
or nude adult mouse recipients reveal that the isografts un-
dergo appropriate region-specific development in the ab-
senceofluminal contents (e.g., Rubin et al., 1991) . This ob-
servation suggests that (a) the lumen is not the source of
positional information and (b) stem cells are programmed
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with "spatial memory" before the appearanceofthe epithelial
monolayer and the formation of a mature crypt-to-villus axis.
The normal mouse small intestine is able to establish a
balance between proliferation and differentiation and to
maintain it in the absence of neoplastic transformation . If
transformation occurs in a lineage descendant, its rapid
migration would be expected to result in its removal from the
epithelial population unless the initiation event simultane-
ously enhanced the probability of self-renewal and functional
anchorage. Alternatively, the already anchored stem cell
may itself be involved in the initiation of gut neoplasia . A
corollary to this latter hypothesis is that gut neoplasms
should arise from single crypts and be monoclonal (Schmidt
and Mead, 1990). This expectation is supported by several
studies of mouse and humanadenomas and carcinomas (Oo-
men et al ., 1984 ; Ponder and Wilkinson, 1986; Fearon et
al., 1987; Griffiths et al ., 1989) .
Current models for the origins of human colorectal carci-
nomas indicate that they arise as a consequence ofa number
of genetic mutations (Vogelstein et al., 1989; Fearon and
Vogelstein, 1990) . This multistep model envisions that
progression from premalignant villus adenomas-more dys-
plastic adenomas-frank adenocarcinoma with subsequent
invasion is associated with the accumulation of lesions that
affect oncogenes and several tumor suppressor genes. Al-
though the sequence may be variable, mutation or loss of
genes at the familial adenomatous polyposis (FAP) locus on
chromosome 5 (i .e., the mutated in colon cancer [MCC] and
adenomatous polyposis coli [APC] genes) (Bodmer et al.,
1987; Leppert et al ., 1987; Kinzler et al., 1991a,ó; Groden
et al ., 1991; Joslyn et al., 1991) may lead to the development
of small, monoclonal adenomas. Progression may reflect the
accumulation of mutations in certain oncogenes, such as
K-ras (Forrester et al., 1987; Bos et al., 1987; Vogelstein et
al ., 1988; Farr et al., 1988), as well as deletion or mutation
of the deleted coloncarcinoma (DCC) gene on chromosome
18 and the p53 locus on chromosome 17 (Baker et al., 1989;
Nigro et al., 1989; Fearon et al., 1990) . DCC is normally
expressed in the colonic epithelium and encodes a member
of the cell adhesion glycoprotein family (Fearon et al.,
1990). Its loss or mutation may affect cell-cell and cell-
extracellular matrix interactions. p53 is a 375-residue nu-
clear phosphoprotein that can suppress cellular transforma-
tion in oncogene cooperation assays, possibly through domi-
nant negative effects (Jenkins et al ., 1984; Parada et al .,
1984 ; Eliyahu et al., 1989; Finlay et al ., 1989 ; Marshall,
1991 ; Milner and Metcalf, 1991) .
Additional information about how cell-specific, region-
specific and developmental stage-specific expression of
genes are regulated in the gut is critical for deriving the an-
swers to several important questions concerning intestinal
epithelialtumorigenesis. (a) Why does the incidence or type
of cancer vary as a function of position along the duodenal-
to-colonic axis? (b) Are stem cellsthe site of initiation of the
transformation? (c) To what extent are the normal pathways
for commitment and differentiation retained in these neo-
plasms and (d) can they be modulated in vivo?
Recently, a mouse model of intestinal neoplasia has been
identified (Moser et al., 1990). Germline mutagenesis of
C57BL/6J (B6) males by ENU followed by mating to AKR/J
(AKR) females yielded a pedigree carrying an autosomal
1518dominant mutation that is fully penetrant, producing multi-
ple intestinal adenomas throughout the length of the gas-
trointestinal tract. Min (multiple intestinal neoplasia) mice
have been maintained by crossing Min/+ males with B6 fe-
males. B6-Min/+ mice develop anemia by 60 d of age. Their
average lifespan is 119 t 31 d (Moser et al., 1990). The av-
erage total number oftumors in duodenal, jejunal, ileal, and
colonic segments is 29 ± 10.
In this present study, we have defined cellular differentia-
tion within the tumors of Minl+ mice as a function of both
position along the duodenal-to-colonic axis and age. A sur-
vey was conducted using molecular markers specific for en-
terocytes, enteroendocrine, goblet and Paneth cells. The
products of the homologous, but unlinked, mouse liver and
intestinal fatty acid binding protein genes (Fabpl and Fabpi;
Sweetser et al., 1987) were used as enterocytic markers for
two reasons. First, both genes are expressed as enterocytes
emerge from the crypt, creating a distinctive crypt-to-villus
distribution of their mRNA and protein products (Sweetser
et al., 1988a,ó). Second, each establishes and maintains re-
gional differences in their expression along the duodenal-to-
colonic axis from the time ofinitial cytodifferentiation of the
gut in late gestation through adulthood (Roth et al., 199ía;
Rubin et al., 1991; Cohn et al., 1991) . Fabpl transcription
is confined to the small intestine (and hepatocytes) . The
highest steady-state levels of its mRNA occur in proximal
jejunum, progressively failing as one proceeds to the termi-
nal ileum. No mRNA is detectable in cecum or colon. Ex-
pression ofFabpiis confined to the intestine: the distribution
of its mRNA and protein products along the cephalo-caudal
axis is similar to Fabpl with the exception that it is also tran-
scribed in the cecum and proximal colon (Sweetser et al.,
1988a,ó; Cohn et al ., 1991; Rubin et al., 1991). Thus, an
analysis of Fabpi and Fabpl expression in gut neoplasms al-
lows simultaneous assessment of their ability to support
differentiation and their capacity for retaining positional in-
formation. A similar logic was used when selecting the en-
teroendocrine cell population. While enteroendocrine cells
represent <1% of the gut epithelial cells, they provide sensi-
tive markers for its spatial differentiation. At least 15 differ-
ent cell types have been identified based on their principal
neuroendocrine product. Each cell type has a distinctive dis-
tribution alongthe crypt-to-villus and/or duodenal-to-colon-
ic axes (Rothet al., 1990). Multiple label immunocytochem-
ical studies (Roth et al., 1990; Roth and Gordon, 1990; Roth
et al., 1991x; Rubin et al., 1991) have disclosed complex in-
terrelationships between these populations that suggest, in
certain cases, sequential expression of different endocrine
products during their migration/differentiation along the
crypt-to-villus axis. It is possible to exploit the complexity
of the gut's enteroendocrine cell population to infer the bio-
logical properties of this multipotent stem cell (e.g., spatial
memory, and regulation ofcommitment/differentiation of its
descendants) . Analysis of enteroendocrine populations rep-
resented in adenomatous lesions distributed along the prox-
imal-to-distal axis of the gut in B6-Minl+ mice offered the
promise notonly ofassessing their ability to retain positional
information but also determining whether they are initiated
in the stem cell (Roth et al., 1991b) or in its descendants. The
presence of goblet cells within the tumors was assessed with
histochemical stains for mucin. Because Paneth cells nor-
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mally arise during a downward migration/differentiation to
the crypt base, theirpresence or absence from these lesions
should provide additional insights not only aboutthe cellular
target in which the Min mutation initiates tumor formation
but also aboutthe capacity ofPaneth cells to arise in the ab-
sence of a well organized crypt-to-villus axis. (This latter
point also applies to all of the cellular markers studied.)
Finally, genetic studies have revealed an unlinked modifier
locus or loci that affect(s) the number oftumors that develop
in Min mice and allowed us to examine the biological proper-
ties of these lesions in older animals. Our data suggest
that the Min mouse represents a powerful model system for




All mice were bred at the McArdle Laboratory for Cancer Research from
C57BL6/J (B6), AKR/J(AKR)or MA/MyJ (MA) micethat were purchased
from the JacksonLaboratory (Bar Harbor, ME). The Min pedigree is main-
tainedby crossingMinl+ males withB6 females. Fl animals wereproduced
by crossing 86 Min/+ males (N4-N10) with AKR, MA or (AKR x MA)
F1 females. The backcross progeny were produced by mating Fl Minl+
mice ofeithersex with B6 mice. These matings were setup beforedetermin-
ing the genotype of the Fl parent with respect to Min. The genotype was
then established retrospectively by progeny test and by examination of the
intestine of the Fl animals. Only the progeny from Fl mice shown to carry
Min were included in the backcross set.
Tumor Scoring
Anemia provides an early and sensitive phenotypic marker of Min (Moser
et al., 1990). Anemic mice were identified by pallor or by low hematocrit.
Animals were killed by C02 asphyxiation when moribund or at 300 d of
age. The intestinal tract from duodenum to colon was removed. Sections
4-cm in length were harvested from duodenum, jejunum, and ileum (see
Sweetser et al., 1988a for a description ofhow these regions are operation-
ally defined), opened longitudinally, and washed in PBS. The entire colon
was treated in an identical manner. Tumors were counted under the dissect-
ing microscope (at lox magnification). The smallest scorable tumors were
-0.5 mm in diameter.
Immunocytochemical Methods
Unopened duodenal, jejunal, ileal, and colonic segments were fixed over-
night in Bouin's fluid, transferred to 70% ethanol and subsequently embed-
ded inparaffin. Alternatively, fixed tissues wereincubated overnight inPBS
containing sucrose (10% wt/vol) and frozen for cryostat sectioning. 5-Am-
thick paraffin sections or 10-,um-thick frozen sections were prepared from
adenomas randomly harvested from each segment as well as normal appear-
ing epithelium (n = six 131-140-d-old B6-Minl+ mice; and two 304-d-old
Fl mice from AKR x B6-Min/+ and MA x B6-Min/+ intercrosses).
Paraffin sections were treated with xylene and rehydrated in graded
ethanols, H2O, and PBS. Cryostat sections were briefly brought to room
temperature and rehydrated with PBS. Rehydrated sections were thenprein-
cubated for 30 min in PBS containing 0.2% nonfat powdered milk, 2 %
BSA, and 0.3% Triton X-100. Primary antisera were diluted in this buffer
and incubated with the sections at 4°C overnight. After a series of PBS
washes, sections were incubated for 1 h with gold-labeled goat antirabbit
serum, subsequently washed with PBS and water and bathed in silver en-
hancement solution using a protocol supplied by the manufacturer (Amer-
shamCorp., Arlington Heights, IL). Silver precipitation was monitoredun-
der the light microscope and the reaction terminated by a series of water
washes. Sections were lightly counterstained with hematoxylin.
Alternatively, antigen-antibody complexes were detected with fluores-
cent-labeled secondary antibodies (Jackson Immunoresearch Laboratories,
West Grove, PA). Methods for multiple labeling using simultaneous im-
munofluorescence or sequential immunogold silver/immunofluorescence
1519staining have been described in earlier publications (Roth et al., 1990; Roth
and Gordon, 1990) .
The following antisera were used for these studies (their final dilutions
for immunogold silver staining [IGSS] and sources are listed in paren-
theses): rabbit antirat liver fatty acid binding protein (L-FABP, 1:1,000,
Sweetser et al., 19ß8a), rabbit antirat intestinal fatty acid binding protein
(I-FABP, 1:1,000, Sweetser et al ., 198ßb), rabbit antihuman lysozyme
(1:1,000, Dako Corp., Santa Barbara, CA), rabbit or goat antiserotonin
(1:2,000, Incstar Corp, Stillwater, MN), rat antiserotonin (1:2,000, Eugene
Tech, Allendale, NJ) rabbit antisubstance P (1:2,000, Roth and Gordon,
1990), rabbit antigastric inhibitory peptide (GIP, 1:1,000, Peninsula Lab-
oratories, Belmont, CA), rabbit antiglucagon-like peptide 1 (GLP-1, resi-
dues 1-19, 1:1,000, Peninsula), rabbit anticholecystokinin (CCK, residues
1-39, 1:1,000, Peninsula), rabbit antineurotensin (1:1,000, Incstar), rabbit
antipeptide tyrosine tyrosine (PYY, TRQR43 from C. J. Evans, UCLA,
1:2,000), rabbit antisomatostatin (1:1,000, Incstar), and rabbit antipan-
creatic polypeptide (PP, 1:1,000, Dako). The immunostaining characteris-
tics and unique specificities of these sera are demonstrated in previous
reports (Roth et al., 1990; Roth and Gordon, 1990).
Goblet cells were identified with two separate histochemical stains for
mucin: (a) mucicarmine and (b) periodic acid-Schiff (PAS) stain with
«-amylase pretreatment to remove glycogen.
Results
B6-Minl+ mice develop intestinal tumors throughout the
duodenal-to-colonic axis. These tumors appear as adenoma-
tous polyps with moderate dysplasia, mild nuclear atypia,
and frequent mitotic figures (Fig. 1 A). Surveys of 28 lesions
harvested from six animals ranging in age from 131 to 140 d
revealed no obvious morphologic differences between le-
sions as a function oftheir position alongthe cephalo-caudal
axis. No invasive adenocarcinomas were identified in these
six mice.
Fabpl and Fabpi Expression in Intestinal
Tumors IsAffected by Their Pbsition along the
Duodenal-to-Colonic Axis
A minority of the cells in serially sectioned, small intestinal
neoplasms harvested from six B6-Min/+ mice reacted with
L-FABP antibodies. L-FABP-immunoreactive cells were
found in patches distributed among histologically identical
L-FABP-negative cells. Fig. 1, B and C show results that are
representative of those obtained from 18 serially sectioned
adenomas. By contrast, L-FABP-positive cells were not
present in any of the colonic lesions in the three animals we
surveyed. Patches of I-FABP-immunoreactive cells were
also encountered in 8 of 10 small intestinal adenomas that
were serially sectioned and appeared similar to L-FABP-
positive patches (data not shown). However, unlike Fabpl,
Fabpi was also expressed in proximal colonic, but not distal
colonic, adenomas (n = 3 animals) . Thus, although these
proteins accumulated in only a small subpopulation of cells,
theirpatterns of expression in small and large intestinal ade-
nomas appear to recapitulate the normal regional specificity
ofFabpiand Fabpltranscription in the adult mouse intestine.
It is important to note that immunostaining of normal-ap-
pearing duodenal, jejunal, ileal, and colonic epithelium in
six B6-Min/+ mice indicated that the Min mutation had
no effect on the distribution of L-FABP and I-FABP along
the crypt-to-villus and duodenal-to-colonic axes when com-
pared to their distributions in three normal littermates (data
not shown) .
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Surveys ofEnteroendocrine Pbpulations in B6-Min/+
Mouse Intestinal Adenomas
Serotonin-immunoreactive cells are distributed throughout
the length of the mouse intestinal tract and represent the
largest enteroendocrine cell population in the normal adult
mouse gut (Roth et al ., 1990) . Serotonergic cellswere pres-
ent in all 18 adenomas examined independent of their loca-
tion along the cephalo-caudal axis (Fig. 1 E). Of the 11 en-
teroendocrine cell types examined (see below), this type was
encountered most frequently. The number of serotonin-
immunoreactive cells in a given adenoma ranged from one
to two cells per section to -5% of all tumor cells/section .
Unlike L-FABP-positive and I-FABP-positive enterocytes,
these enteroendocrine cellswere diffusely scattered through-
out the lesion and not clustered in discrete patches of contig-
uous cells or in discrete regions of adenomas.
Substance P-immunoreactive cells are found throughout
the normal mouse small intestine and proximal colon but are
rare in the distal colon (Roth et al ., 1990 ; Roth and Gordon,
1990). Immunocytochemical studies indicated that sub-
stance P cells represented <1% of the cells/section in 18 of
the 20 serially sectioned small intestinal and proximal co-
lonic tumors we examined. No substance P-immunoreactive
cellswere detected in the distal colonic lesions ofthree -140-
d-old B6-Min/+ animals.
In normal B6 mouse intestine (and in regions of normal
appearing gut in B6-Minl+ animals), substance P was fre-
quently colocalized with serotonin in the same cell. Coex-
pression of these neuroendocrine products is normally
influenced by cellular location alongthe crypt-to-villus axis
(Roth et al ., 1990; Roth and Gordon, 1990). Substance
P-immunoreactive cells in the adenomas typically contained
serotonin (Fig. 1, D-F) . Since there are many more sero-
tonin-immunoreactive cells than substance P-immunoreac-
tive cells in these lesions, most serotonin-positive cells were
substance P-negative.
Secretin-immunoreactive cells are normally limited to the
small intestinal villus (Roth et al ., 1990). Previous studies
revealed complex interrelationships between substance P-,
serotonin- and secretin-immunoreactive cells (Roth and
Gordon, 1990). The percentage of cells that coexpress sub-
stance P and serotonin, or serotonin and secretin is affected
by their location along the crypt-to-villus axis. These ob-
servations suggested a migration-dependent differentiation
program that involves sequential expression of substance P,
serotonin, and secretin (Both and Gordon, 1990), and indi-
cate thatthe three cell types are sensitive markers ofdifferen-
tiation along this axis. No secretin cells were found in any
of the 11 serially sectioned tumors examined that arose in in-
testinal segments which normally contain this enteroendo-
crine cell population. This includes adenomas that contain
cells which express substance P or serotonin alone or those
that coexpress both of these neuroendocrine products.
The representation of other enteroendocrine cell types in
tumors reflects their distribution along the duodenal-to-
colonic axis of the normal gut and the site of origin of the
tumor. For example, neurotensin-positive cells are present
throughoutthe entire intestine ofnormal adult B6 mice (Roth
et al., 1990) . Rare (<1%) neurotensin-immunoreactive cells
were found in both small and large bowel tumors (n = 3 of
8 tumors). Gastric inhibitory peptide (GIP)-, gastrin-, and
1520Figure 1 . Immunocytochemical studies ofcellular differentiation in Min intestinal neoplasms . (A) Hematoxylin and eosin-stained section
from the proximal jejunum ofaB6-Min/+ mouse shows a typicaladenoma protruding into the intestinal lumen (100x) . Adenomas arising
in the small intestine frequently contained L-FABP-immunoreactive cells. Small patches of L-FABP containing cells in two separatejejunal
adenomas are seen inBandC . L-FABP was detected with a rabbit anti-L-FABP antiserumand either the immunogold silver staining (IGSS)
method (B) or with fluorescein-labeled second antibodies (C) . L-FABP cells occurred scattered individually throughout the tumor, as in
B, and/or incontiguous groupsof intensely labeled cells, as in C . Min+ adenomas frequently contained enteroendocrine cell subpopulations
characteristic of the intestinal segment in which they arose andcomplexenteroendocrine cell interrelationships appeared to be maintained .
D-Fdemonstrate the colocalization of substance P and serotonin immunoreactivity within a jejunal adenoma . The tumor tissue was first
incubated with rabbit antisubstance P serum and detected with IGSS, followed by rat antiserotonin serum which was detected with
0-phycoerythrin-labeled donkey antiratserum.A substance P-immunoreactive cell is seen in D, visualized with reflected light-polarization
microscopy. A single serotonin-immunoreactive cell is seen in E . Double exposure of the section in F clearly shows the colocalization
of substance Pandserotonin in this cell . Colonic tumors contained enteroendocrine cell subpopulations appropriate for this intestinal seg-
ment . A section from a distal Coonic adenoma immunostained for PYY shows two immunoreactive cells in G. This cell type is largely
confined to the colon andtumors arising in the small intestine did not containPYYimmunoreactive cells . Lysozyme immunoreactive cells
were found in adenomas throughout the intestine. Small intestinal tumors contained relatively frequent, intensely labeled cells (H) while
large intestinal tumors had fewerand weaker stained cells (I). (B-I, 400x). Small intestinal segments from two 304-d-oldMA x AKR
(Min+) mice showed invasive adenocarcinomas . A hematoxylin and eosin-stained section from ajejunal tumordemonstrates amoderately
differentiated adenocarcinoma extending into the intestinal muscularis (J, 200x) . Enterocytic, enteroendocrine, goblet and Paneth cell
differentiation was found in theadenocarcinomas.Kshows a patch of L-FABP immunoreactive cells and L several serotonin cells in the
neoplasm invading into the muscularis (400x) . Lysozyme-positive Paneth cells and mucin-containing goblet cells were also detected in
these tumors (data not shown) .
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152 1cholecystokinin (CCK)-immunoreactive cells are normally
restricted to the small intestine (Roth et al., 1990). Rare
(<1%) GIP-, gastrin- and CCK-positive cells were noted in
small bowel adenomas (three of seven, one of six, and five
of six tumors, respectively) but not in colonic lesions (n =
4 tumors examined for each polypeptide). Glucagon-like
peptide-1 (GLP-1) cells are more abundant in normal colonic
epithelium compared to small intestinal epithelium (Roth et
al., 1990). Incontrast, peptide tyrosine tyrosine (PYY) cells
are rare in the small intestine but are present in moderate
numbers in the normal colon (Both et al., 1990). Similarly,
pancreatic polypeptide (PP) immunoreactive enteroendo-
crine cellsare essentially confined to the normal distal colon
(Roth et al., 1990). The representation of each of these cell
types (i.e. GLP-1, PYY and PP) in B6-Minl+ neoplasms
harvested from duodenum, jejunum, ileum, proximal, and
distal colonwas appropriately position dependent (e.g., see
Fig. 1 G; n = 2-6 adenomas/segment).
Mucin-Containing Goblet Cells
In all 28 tumors examined, PAS positive (after a amylase
pretreatment) and mucicarmine-positive cells were identi-
fied (data not shown). These cells had the typical histologic
appearance of mucin-containing goblet cells and were found
scatteredthroughoutthetumors as individual or smallgroups
of cells.
SurveysofLysozymeproducing Cells
In normal B6 mice, Paneth cells are located at the base of
small intestinal crypts. Lysozyme-positive Paneth cells are
much less frequent in colonic crypts. This asymmetric distri-
bution was recapitulated in B6-Minl+ neoplasms harvested
along the duodenal-to-colonic axis. Fig. 1 H illustrates the
frequency of lysozyme immunoreactive cells found in 19
small intestinal tumors we surveyed (<10% of neoplastic
cells). In all these adenomas, lysozyme-positive cells were
more numerous than the most abundant enteroendocrine cell
subpopulation (i.e., those that were serotonin-positive) but
always less populous than L-FABP-positive cells and the
undifferentiated cells. Staining was also noted in colonic le-




We attempted to identify genetic conditions that would alter
the temporal pattern ofexpressionofthe Min phenotype. We
reasoned that ifsuch alterations were to lengthen the lifespan
ofthe affected animals, it mightbe possible to assess the time
courseoftumor formation and progression under controlled
conditions. We therefore tested the phenotype of Minl+
mice hybrid between B6 and the inbred strains AKR or MA.
Male Minl+ mice from the B6 line were crossed with fe-
males from these strains and the resulting Fl generation
animals were killed when moribund or at 300 d of age. The
intestines were removed and scored for tumors. The tumors
were counted in four regions: the duodenum, jejunum, il-
eum, and colon. In each set of Fl Minl+ mice, the number
oftumors was greatly decreased and the average lifespan was
greatly increased compared to the B6 Minl+ mice (Table I) .
The average total tumor number for the hybrid Minl+ ani-
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mals was 7 for the (MA x 136) Fl and 6 for the (AKR x
B6) F1 as compared with 29 for B6 Minl+ mice. In each
cross, -50% of the Fl generation (AKR, 13 of 28 animals;
MA, 9 of 14 animals) developed tumors, indicating that Min
is fully penetrant in the hybrid animals. This was more fully
substantiated by progeny testing of eight of the tumor-free
(AKR x 116) Fl mice by crossing with B6 mice. In no case
did any of these phenotypically normal mice give rise to
tumor-bearing progeny. These analyses indicate that there
are alleles carried by these two strains, AKR and MA, that
can act dominantly to modify the action of Min resulting in
a decreased number of tumors.
Most of the hybrid animals in the first set were not scored
until 300 d of age. To analyze the time course of tumor for-
mation, another series of (AKR x B6-Minl + ) Fl mice was
produced and sacrificed at 100 or 175 d of age and examined
for tumors. Again, close to 50% of the animals had tumors
(13 of 27 animals at 100 d; 12 of 21 animals at 175 d), indi-
cating that even at 100 d the tumor phenotype of Min is fully
penetrant on hybrid background. The tumor multiplicities of
the Minl+ Fl animals sacrificed at 100 or 175 d of age were
indistinguishable from those of the Fl mice killed at 300 d
of age (Table I) . As tested by the Wilcoxon Rank Sum Test,
the only significant difference in the tumor multiplicities at
different ages was between 104 and 175 d (P = 0.04). There-
fore, new tumors seem not to arise continually over the
lifespan of the animals. Rather, it seems that most tumors are
established before 100 d of age.
Characterization ofthe lbmors in FI Animals
The tumors present in the hybrid animals were typically ade-
nomas with the phenotypic characteristics of the B6 Minl+
lesions described above. However, the longer lifespan of
these animals afforded us the opportunity to assess tumors
in animals over 300 d ofage. Since the time course analysis
described above indicated that most ofthe tumors are present
before 100 d of age, the tumors in these older animals had
been growing for over 200 d. In contrast to younger mice,
surveys of two such 304-d-old mice disclosed focally inva-
sive adenocarcinomas in the small intestine (Fig. 1 J). These
adenocarcinomas showed moderate degrees of cellular ana-
plasia and nuclear atypia. As in the case of the adenomas,
they contained patches ofL-FABP-positive and I-FABP-posi-
tive cells, a variety of enteroendocrine populations, mucin-
containing goblet cells, and lysozyme-immunoreactive cells
(Fig. 1, K and L) . The position-dependent occurrence of
these cellsparalleled that notedin adenomatous lesions pres-
ent in the same F1 animal and in the younger B6-Minl+ mice
described above. These analyses indicate that, given time,
some ofthe adenomas can progress to adenocarcinomas and
yet retain residual differentiative capacity.
Initial Genetic Characterization of
theModifierSystem
To ascertain whether this modifier system maps to the Min
locus and to investigate its genetic complexity, a backcross
analysis was performed. Fl Minl+ animals from each set
were crossed to B6 animals to produce a segregating back-
cross generation. Animals were killed when moribund or at
300 d of age. Each intestinal tract was then scored for the
presence of tumors as described for the Fl sets.
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The AKR backcross set consisted of 154 animals, 77 of
which were scored as Minl+ . The MA backcross set in-
cluded 148 animals, 83 of which were Minl+ . There were
no differences in the average total tumor number owing to
the sex of the F1 Minl+ parent or the sex of the backcross
animal . Also, equal numbers ofMinl+ females and males
were recovered . The average total tumor multiplicities for
the AKR andMA backcross generations, 16 t 12 and 16
t 11, fell between the F1 andB6 Minl+ numbers (see Table
I) . The distributions oftumor numbers for the backcross, Fl
and B6 Minl+ mice are shown in Fig . 2 . The distributions
are broad, encompassing both parental distributions . These
data are consistent with the presence of a single modifier lo-
cus with major effects that are unlinked to Min .
Discussion
Phenotypic analysis of the multiple intestinal neoplasia mu-
tation has indicated that the adenomatous lesions in B6-
Minl+ mice contain a complex population ofundifferentiated
and differentiated cells . The presence of enteroendocrine,
enterocytic, goblet, and Paneth cells within a given tumor,
together with the fact that expression ofgene products within
these cells is appropriate for the position occupied by the tu-
mor along the duodenal-to-colonic axis, suggest that these
adenomas may arise from a single, mutated, multipotent
stem cell in a crypt. Further genetic analysis has disclosed
a single, major modifier locus unlinked toMin in AKR and
Moser et al . A Murine Genetic Model ofIntestinal Neoplasia
￿
1523
MA strains. This modifier results in a reduction in number
of adenomas and an increase in lifespan. Older hybrid Minl+
animals develop focally invasive adenocarcinomas . These
observations indicate that the Min mouse (a) defines a single
gene (Min) that can affect the normal balance between pro-
liferation and differentiation in the gut epithelium; (b) pro-
vides an opportunity for further characterization ofmultipo-
tent intestinal stem cells ; and (c) together with the modifier
system represents an opportunity to define steps that can lead
to the evolution of intestinal neoplasia .
Is theMultipotentCryptStem Cell theSite of
Initiation of71imorigenesis inMin Mice?
The presence of multiple differentiated cell types in human
colorectal and mouse intestinal neoplasms has been de-
scribed in several reports (Kirkland, 1986 ; 1988 ; van den
Ingh et al., 1986 ; Carroll et al ., 1990 ; Oomen et al ., 1984) .
Although they represented only a minor fraction of the total
cellular population, their existence suggests the possibility
that these lesions arose from a progenitor cell and that the
capacity to differentiate along a number of pathways was re-
tained during initiation and progression of the neoplasm .
The ability of such lesions to generate multiple lineages has
also been reproduced in culture : several cell lines derived
from human colonic adenocarcinomas (e.g., HT29 and
HRA-19) are able to produce enteroendocrine, goblet, and
enterocyte-like descendants (Pinto et al., 1982 ; Huet et al.,
1987) .
Figure 2. Tumor multiplicity in Minl+ mice from theAKR andMA backcrosses . To analyze the system of modifiers in the AKR (A)
andMA (B) strains, hybrid Minl+ animalswere backcrossed to B6 mice . Thecrosses were done in each parental orientation. Mice result-
ing from such backcrosseswere scored forMinandtumorcounts were performed . Theaverage number oftumors formice in each genera-
tion is given in the text . Thedistributionsoftumornumber fortheMinl+ mice from each backcross generation (hatchedbars) arecompared
with those of the Minl+ Fl hybrid parents (solid bars), and B6-Minl+ mice (open bars) .





number of tumors among
tumor-bearing mice f SD
In colon Total
d
B6 118 t 26 68 29 24t7.2 5t4.3 29t7.5
MAxB6 349 t 102 14 9 6 t 3.1 1 t 1 .7 7 f 3.7
AKRxB6 293 t 52 28 13 5 t 4.8 0.9 t 1 .0 6 f 4.7
AKRxB6 175 f 4 21 12 7 t 5.1 0.8 t 1 .3 8 t 4.8
AKRxB6 104 t 1 27 13 3 t 1 .8 0.6 t 1 .0 4 f 2.6Finding multiple, differentiated cell types in Min ade-
nomas and the retention of position-dependent differences in
enterocytic and enteroendocrine differentiation programs
within these lesions is fully consistent with initiation within
a multipotent stem cell . If a stem cell is the site of initiation
oftumorigenesis, then itcan already provide the potential for
multiple differentiation programs, spatial memory (see In-
troduction) as well as functional anchorage and an enormous
capacity for renewal. The chance that a single germline
mutational event would yield such a complex constellation
of biological properties in any other cell located along the
crypt-to-villus axis seems improbable. Given the rapid
migration of cells along the axis, it also seems implausible
that multiple independent or interdependent somatic events
could accumulate to yield the necessary array of proposed
properties ofthe initiated cell. It remains to be seen whether
the multipotential stem cell population that we believe may
serve as the source of the Min adenomas corresponds pre-
cisely to any normal intestinal stem cell population, and
whether the growth of the adenoma is clonal or, as in neo-
natal intestinal epithelium, polyclonal .
TheModifier System ofthe Min Phenotype
The incidence of intestinal tumors due to the action of Min
is reduced in mice ofFl hybrid genetic backgrounds contain-
ing a contribution from AKR or from MA . The resistance
factor(s) of AKR and MA are either codominant or fully
dominant. We do not yet know whether the sensitive B6
background represents the null allele(s) of resistance fac-
tor(s), or whether it contributes codominant susceptibility
determinants. Further genetic analysis, including mapping
ofthe modifier system, is necessary to assess fully its genetic
structure in AKR and MA, and its formal mode of action.
We can state unambiguously, however, that the modifier sys-
tem is not encoded entirely at the Min locus. If it were, resis-
tance would segregate from Min in the backcross progeny
and all Min/+ animals would match the B6-Min/+ mice in
tumor multiplicities.
A number of instances of parental imprinting have been
reported recently for genetic disorders in the human, includ-
ing heritable cancer syndromes (Reik, 1989 ; Hall, 1990) .
We have, therefore, askedwhether the action of the modifier
system shows evidence for parental imprinting. Neither the
sex of the Fl parent nor the sex of the backcross progeny was
correlated with tumor multiplicity. Therefore, no evidence




The modifier system has permitted the study of tumor for-
mation and progression over an extended age range in hy-
brid Min/+ animals. This analysis indicates that most, if
not all, tumors are initiated before 100 d of age. Thus, the
probability of tumor formation is not constant with age;
Min-induced neoplasms seem to be juvenile lesions. In prin-
ciple, the staging ofMin-induced tumors can reflect changes
in the expression of the mutant Min gene and/or changes in
the susceptibility ofthe target cell population. More precise
investigations of the staging of tumor formation are called
for, in particular to know whether there is a window of sus-
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ceptibility at the neonatal stage during which time crypt line-
ages are polyclonal (Schmidt et al., 1988). One must keep
in mind in this context that even on a sensitive background,
the number ofMin-induced tumors is very small in compari-
son to the total number of stem cells in the intestinal tract;
tumor formation is a low probability event.
Given time, Min-induced tumors can progress to more in-
vasive forms. Such invasiveness may be an intrinsic property
of the undifferentiated cell population comprising the early
adenomas, or it may depend upon further somatic mutational
events that occur during proliferation of non-invasive ade-
noma stem cells. The Min mouse strain permits investigation
of the process of progression by providing a uniform back-
ground upon which defined environmental or genetic modi-
fications can be introduced.
Prospectus
In this report, we have described a further refinement ofthe
genetic system ofthe mouse defined by the dominant mutant
allele Min, multiple intestinal neoplasia. The modifier sys-
tem is used experimentally to permit the observation ofMin-
induced tumors over a longer time period than that afforded
on the B6 background. The system is not yet characterized
in genetic detail, nor at the molecular level.
A number of issues are raised by the studies reported here.
In surveys of B6- or hybrid-Min/+ adenomas, the majority
ofcellsdid not react with lineage specific markers. What are
these cells? Do they represent an inappropriate expansion of
a normal class of cells-e.g., one which normally resides in
the crypt such as its transit cell population (see Potten and
Loeffler, 1990)? Given the dynamic balance maintained be-
tween proliferation and differentiation in the normal crypt,
would the expansion of such a cellular compartment repre-
sent an unbalanced proliferation or the elimination of a
maturation process? Transgenes may represent a powerful
tool to characterize further this predominant, undifferen-
tiated cellular population present in Min adenomas. As noted
above, Fabpl is a sensitive marker of enterocytic differen-
tiation. Linkage of nucleotides -4,000 to +21 or -596 to
+21 of the rat L-FABP gene to several reporters produces
a pattern of reporter mRNAand protein accumulation along
the duodenal-to-ileal axis which mimics that of the intact
endogenous Fabpl gene but produces inappropriate (preco-
cious) expression in the crypt where Fabpl is normally silent
(Sweetser et al ., 1988a; Hansbrough et al., 1991) . Crossing
Min heterozygotes with L-FABP/reporter transgenics will
afford an opportunity to assess whether transgene expression
is supported in the seemingly undifferentiated cells of Min
adenomas and thereby operationally define similarities to
crypt epithelial cells. Investigating growth factor and growth
factor receptor gene expression in the adenomatous lesions
and the normal appearing crypts of Min/+ mice, and in the
crypts of wild type mice may provide clues about the mecha-
nisms that establish and maintain the balance between pro-
liferation and differentiation along the crypt-to-villus axis.
Finally, what are the molecular identities of the Min locus
and the modifier system? What are the normal physiologic
functions and mechanisms of action of the wild type Min
allele and its modifiers? Progress both in the molecular ge-
netics ofthe mouse (e.g., Todd et al., 1991) and in the biolog-
ical analysis ofthe intestinalepitheliumpromise to bring an-
swers to these questions.
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